Review article: current management of renal dysfunction in the cirrhotic patient

被引:24
作者
Pham, PTT [1 ]
Pham, PCT [1 ]
Rastogi, A [1 ]
Wilkinson, AH [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1111/j.1365-2036.2005.02357.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The United Network for Organ Sharing database revealed that over the last 4-5 years, an average of 1800 patients were removed from the cadaveric waiting list annually because of patients' death and an additional 400-500 were removed from the list because of the severity of their illnesses.(1) The pre-transplant evaluation process, therefore, requires careful and continued assessment of the patient's pulmonary, cardiac and renal function among others. This article describes a systematic approach to the evaluation and management of renal dysfunction complicating the course of advanced liver disease, the pathogenic mechanisms and current recommendations for the treatment of hepatorenal syndrome, and the indications for combined liver-kidney transplantation.
引用
收藏
页码:949 / 961
页数:13
相关论文
共 93 条
[1]   A ROLE FOR HEPATITIS-C VIRUS-INFECTION IN TYPE-II CRYOGLOBULINEMIA [J].
AGNELLO, V ;
CHUNG, RT ;
KAPLAN, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1490-1495
[2]   Hepatorenal syndrome:: from physiopathology to treatment [J].
Aguillon, D ;
Seguin, P ;
Mallédant, Y .
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2003, 22 (01) :30-38
[3]   Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial [J].
Akriviadis, E ;
Botla, R ;
Briggs, W ;
Han, S ;
Reynolds, T ;
Shakil, O .
GASTROENTEROLOGY, 2000, 119 (06) :1637-1648
[4]   Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2 [J].
Alessandria, C ;
Venon, WD ;
Marzano, A ;
Barletti, C ;
Fadda, M ;
Rizzetto, M .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2002, 14 (12) :1363-1368
[5]   Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide [J].
Angeli, P ;
Volpin, R ;
Gerunda, G ;
Craighero, R ;
Rone, P ;
Merenda, R ;
Amodio, P ;
Sticca, A ;
Caregaro, L ;
Maffei-Faccioli, A ;
Gatta, A .
HEPATOLOGY, 1999, 29 (06) :1690-1697
[6]  
Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1002/hep.510230122
[7]   LIMITATIONS OF SERUM CREATININE LEVEL AND CREATININE CLEARANCE AS FILTRATION MARKERS IN CIRRHOSIS [J].
CAREGARO, L ;
MENON, F ;
ANGELI, P ;
AMODIO, P ;
MERKEL, C ;
BORTOLUZZI, A ;
ALBERINO, F ;
GATTA, A .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (02) :201-205
[8]   Is there a role for continuous renal replacement therapies in patients with liver and renal failure? [J].
Davenport, A .
KIDNEY INTERNATIONAL, 1999, 56 :S62-S66
[9]   Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I. [J].
Davis, CL ;
Gonwa, TA ;
Wilkinson, AH .
LIVER TRANSPLANTATION, 2002, 8 (02) :91-109
[10]  
di Belgiojoso GB, 2002, J NEPHROL, V15, P469